Abstract
To better understand genetic alterations in oral premalignant lesions, we examined 84 oral leukoplakia samples from 37 patients who had been enrolled in a chemoprevention trial. The samples were analyzed for two microsatellite markers located at chromosomes 9p21 and 3p14. Loss of heterozygosity (LOH) at either or both loci was identified in 19 of the 37 (51%) patients. Of these 19 patients, seven (37%) have developed head and neck squamous cell carcinoma (HNSCC) while only one of 18 (6%) of patients without LOH developed HNSCC. Our data suggest that clonal genetic alterations are common in oral premalignant lesions; that multiple genetic alterations have already occurred in oral premalignant lesions, allowing at least a focal clonal expansion; and that losses of the 9p21 and 3p14 regions may be related to early processes of tumorigenesis in HNSCC. These genetic alterations in premalignant tissues may serve as markers for cancer risk assessment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Silverman, S., Jr., Gorsky, M. & Lozada, F. Oral leukoplakia and malignant transformation: A follow-up study of 257 patients. Cancer 53, 563–568 (1984).
Bánóczy, J. & Csiba, A. Comparative study of the clinical picture and histopathologic structure of oral leukoplakia. Cancer 29, 1230–1234 (1972).
Lippman, S.M. et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N. Engl. J. Med. 328, 15–20 (1993).
Hong, W.K. et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 153, 1501–1505 (1986).
Silverman, S., Jr., Gorsky, M. & Lozada, F. Oral leukoplakia and malignant transformation. Cancer 53, 563–568 (1984).
Sidransky, D. Molecular genetics of head and neck cancer. Curr. Opin. Oncol. 7, 229–233 (1995).
Field, J.K. et al. Allelotype of squamous cell carcinoma of the head and neck: Fractional allele loss correlates with survival. Br. J. Cancer 72, 1180–1188 (1995).
Nawroz, H. et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 54, 1152–1155 (1994).
van der Riet, P. et al. Frequent loss of chromosome 9p21–22 early in head and neck cancer progression. Cancer Res. 54, 1156–1158 (1994).
Cairns, P. et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nature Genet. 11, 210–212 (1995).
Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994).
Zhang, S. et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res. 54, 5050–5053 (1994).
Merlo, A. et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1, 686–692 (1995).
Naylor, S.L., Johnson, B.E., Minna, J.D. & Sakaguchi, A.Y. Loss of heterozygosity of chromosome 3p in small-cell lung cancer. Nature 329, 451–454 (1987).
Maestro, R. et al. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res. 53, 5775–5779 (1993).
Ohta, M. et al. The FHIT gene, spanning the chromosome 3pl4.2 fragile site and renal carcinoma associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587–597 (1996).
Kishimoto, Y. et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J. Natl. Cancer Inst. 87, 1224–1229 (1995).
Hung, J. et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc. 273, 558–563 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mao, L., Lee, J., Fan, Y. et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2, 682–685 (1996). https://doi.org/10.1038/nm0696-682
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0696-682
This article is cited by
-
Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Oral Cavity Dysplasia: Why Does Histologic Grading Continue to be Contentious?
Head and Neck Pathology (2023)
-
Application of 5-aminolevulinic acid-mediated Waterlase-assisted photodynamic therapy in the treatment of oral leukoplakia
Scientific Reports (2022)
-
Open questions and novel concepts in oral cancer surgery
European Archives of Oto-Rhino-Laryngology (2016)
-
Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment
BMC Cancer (2015)
-
Downregulation of CRNN gene and genomic instability at 1q21.3 in oral squamous cell carcinoma
Clinical Oral Investigations (2015)